Biocide Registration in the USA & Canada: Requirements & Testing Guide
Advanced laboratory testing for biocide registration compliance in the USA and CanadaBiocides—antimicrobial products, disinfectants, preservatives, and pesticides that control harmful organisms—must undergo rigorous regulatory review before they can be manufactured, sold, or used in the United States and Canada. The registration process requires comprehensive efficacy testing, toxicology studies, environmental fate data, and physicochemical characterisation to demonstrate product safety and effectiveness. For companies seeking biocide testing at a US-based testing lab, Infinita Lab provides comprehensive analytical and material testing services through its accredited laboratory network.
US Regulatory Framework
EPA FIFRA Registration
In the United States, the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) requires that all antimicrobial pesticides and biocides be registered with the Environmental Protection Agency (EPA) before sale or distribution. Registration requires submission of product chemistry, toxicology, efficacy, and environmental fate data.
EPA Product Chemistry Requirements
Registrants must provide the identity and purity of the active ingredient, the product formulation composition, physical and chemical properties (melting point, boiling point, pH, density, solubility), stability data, and container material compatibility per 40 CFR Part 158.
Canadian Regulatory Framework
PMRA Registration Under the Pest Control Products Act
Health Canada’s Pest Management Regulatory Agency (PMRA) registers biocides under the Pest Control Products Act (PCPA). Requirements parallel EPA FIFRA but include Canadian-specific data requirements, bilingual labelling, and assessment criteria.
Testing Requirements
Registration data packages typically include product chemistry and physicochemical properties, acute toxicology (oral, dermal, inhalation LD50), efficacy testing against target organisms per AOAC methods, environmental fate and effects data, residue chemistry for food-contact applications, and accelerated storage stability testing.
Why Choose Infinita Lab for Regulatory Testing?
At the core of this breadth is our network of 2,000+ accredited labs in the USA, offering access to over 10,000 test types. From advanced metrology (SEM, TEM, RBS, XPS) to mechanical, dielectric, environmental, and standardised ASTM/ISO testing, we give clients unmatched flexibility, specialisation, and scale. You are not limited by geography, facility, or methodology—Infinita connects you to the right testing, every time.
Looking for a trusted partner to achieve your research goals? Schedule a meeting with us, send us a request, or call us at (888) 878-3090 to learn more about our services and how we can support you. Request a Quote
Frequently Asked Questions (FAQs)
What is a biocide? A biocide is any substance or product intended to destroy, deter, or control harmful organisms, including bacteria, viruses, fungi, algae, and pests. Examples include disinfectants, sanitizers, preservatives, and antimicrobial coatings.
Which US agency regulates biocides? The US Environmental Protection Agency (EPA) regulates biocides under FIFRA. Antimicrobial products making public health claims are registered through the EPA’s Antimicrobials Division. The FDA regulates antiseptics for use on the human body.
What testing is required for biocide registration? Product chemistry, acute toxicology, efficacy against target organisms, physicochemical properties, environmental fate data, and storage stability are core testing requirements for both EPA and PMRA registration.
How long does biocide registration take in the US? EPA antimicrobial registration typically takes 12–18 months from the time of complete submission. Expedited pathways exist for public health antimicrobials. Data generation and study completion may require an additional 6–12 months before submission.
Can a single registration cover both the US and Canada? No—separate registrations with EPA and PMRA are required. However, the US-Canada Joint Review Program allows parallel evaluation and data sharing, reducing duplicate testing and accelerating approval in both countries.
